RecruitingPhase 3NCT07561827

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery


Sponsor

University of California, San Francisco

Enrollment

42 participants

Start Date

Jun 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.


Eligibility

Min Age: 10 YearsMax Age: 18 Years

Inclusion Criteria2

  • Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis
  • Undergoing Posterior Spinal Fusion (PSF) Surgery

Exclusion Criteria3

  • Patients with forms of scoliosis other than AIS or NM Scoliosis.
  • Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery
  • Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRopivacaine Hydrocloride

This drug is approved as a local anesthetic.


Locations(1)

University of California San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07561827


Related Trials